Apple's iPhone Duo Reportedly Sells Out Moments After Pre-Orders Open - Hypebeast

There's extra savings to be had on top of the deal, too PC Guide is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Read More

Combination strategies enable simultaneous activation and silencing of key target genes to correct molecular pathways in pancreatic cancer. For the first time, scientists have designed combination therapies of small nucleic acid therapeutics based on the specific molecular characteristics of a tumor. These novel therapies work in an opposite but complementary way to regulate gene expression. This innovative approach, tested in pre-clinical models of pancreatic ductal adenocarcinoma (PDAC), shows superior anti-cancer effects compared to single nucleic acid therapies, offering the potential of flexible, precise, and personalized cancer treatments.